Log in to save to my catalogue

Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroid...

Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroid...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8528480

Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults

About this item

Full title

Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults

Publisher

New York: Springer US

Journal title

Reviews in endocrine & metabolic disorders, 2022-06, Vol.23 (3), p.463-483

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Levothyroxine (LT4) is a safe, effective means of hormone replacement therapy for hypothyroidism. Here, we review the pharmaceutical, pathophysiological and behavioural factors influencing the absorption, distribution, metabolism and excretion of LT4. Any factor that alters the state of the epithelium in the stomach or small intestine will reduce a...

Alternative Titles

Full title

Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8528480

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8528480

Other Identifiers

ISSN

1389-9155

E-ISSN

1573-2606

DOI

10.1007/s11154-021-09691-9

How to access this item